Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease-Reference-Cited by-同舟云学术

Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease

Published:2015-08 Issue:8 Volume:99 Page:1644-1651
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Verna Elizabeth C.,Saxena Varun,Burton James R.,O’Leary Jacqueline G.,Dodge Jennifer L.,Stravitz Richard T.,Levitsky Josh,Trotter James F.,Everson Gregory T.,Brown Robert S.,Terrault Norah A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference54 articles.

1. Liver transplantation in the United States, 1999-2008.;Thuluvath;Am J Transplant,2010

2. The association between hepatitis C infection and survival after orthotopic liver transplantation.;Forman;Gastroenterology,2002

3. Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation.;Picciotto;J Hepatol,2007

4. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation.;Berenguer;Am J Transplant,2008

5. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C.;Bizollon T PP, Mabrut;Am J Transplant,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study;Experimental and Clinical Transplantation;2018-04

2. Transplantation Pathology;Macsween's Pathology of the Liver;2018

3. The Marginal Liver Donor and Organ Preservation Strategies;Liver Anesthesiology and Critical Care Medicine;2018

4. Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States;Hepatology;2017-05-27

5. The New Era of Hepatitis C;Clinics in Liver Disease;2017-05